APO RESEARCH · REPORT
Biobanking
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Product & engineering
Understand the product.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Selected research
Industry Research
Biobanking Industry Research Report 2026
Market perspective
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
Read the full market overview
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Report Scope
This report quantifies the global Biobanking market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biobanking.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biobanking Market by Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Biobanking Segment by Type
Equipment
Consumable
Biobanking Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Biobanking Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Equipment
- Consumable
Applications
- Virtual Biobanks
- Tissue Biobanks
- Population Biobanks
Companies covered
- Thermo Fisher
- Beckman Coulter
- Panasonic
- SOL Group
- Promega
- Merck
- Greiner Bio One
- Chart Industries
- Brooks Life Science
- Tecan Group
- QIAGEN
- BD
- Lifeline Scientific
- Hamilton
- So-Low
- TTP Labtech Ltd
- Biolife Solutions
- DNA Genotek
- Custom Biogenic Systems
- LVL Technologies
- BioRep
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biobanking by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Equipment
- 2.2.3 Consumable
- 2.3 Biobanking by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Virtual Biobanks
- 2.3.3 Tissue Biobanks
- 2.3.4 Population Biobanks
- 2.4 Assumptions and Limitations
3 Biobanking Breakdown Data by Type
- 3.1 Global Biobanking Historic Market Size by Type (2021-2026)
- 3.2 Global Biobanking Forecasted Market Size by Type (2027-2032)
4 Biobanking Breakdown Data by Application
- 4.1 Global Biobanking Historic Market Size by Application (2021-2026)
- 4.2 Global Biobanking Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biobanking Market Perspective (2021-2032)
- 5.2 Global Biobanking Growth Trends by Region
- 5.2.1 Global Biobanking Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biobanking Historic Market Size by Region (2021-2026)
- 5.2.3 Biobanking Forecasted Market Size by Region (2027-2032)
- 5.3 Biobanking Market Dynamics
- 5.3.1 Biobanking Industry Trends
- 5.3.2 Biobanking Market Drivers
- 5.3.3 Biobanking Market Challenges
- 5.3.4 Biobanking Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biobanking Players by Revenue
- 6.1.1 Global Top Biobanking Players by Revenue (2021-2026)
- 6.1.2 Global Biobanking Revenue Market Share by Players (2021-2026)
- 6.2 Global Biobanking Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biobanking Head Office and Area Served
- 6.4 Global Biobanking Players, Product Type & Application
- 6.5 Global Biobanking Manufacturers Established Date
- 6.6 Global Biobanking Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biobanking Market Size (2021-2032)
- 7.2 North America Biobanking Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biobanking Market Size by Country (2021-2026)
- 7.4 North America Biobanking Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biobanking Market Size (2021-2032)
- 8.2 Europe Biobanking Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biobanking Market Size by Country (2021-2026)
- 8.4 Europe Biobanking Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biobanking Market Size (2021-2032)
- 9.2 Asia-Pacific Biobanking Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biobanking Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biobanking Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biobanking Market Size (2021-2032)
- 10.2 South America Biobanking Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biobanking Market Size by Country (2021-2026)
- 10.4 South America Biobanking Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biobanking Market Size (2021-2032)
- 11.2 Middle East & Africa Biobanking Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biobanking Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biobanking Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Company Information
- 12.1.2 Thermo Fisher Business Overview
- 12.1.3 Thermo Fisher Revenue in Biobanking Business (2021-2026)
- 12.1.4 Thermo Fisher Biobanking Product Portfolio
- 12.1.5 Thermo Fisher Recent Developments
- 12.2 Beckman Coulter
- 12.2.1 Beckman Coulter Company Information
- 12.2.2 Beckman Coulter Business Overview
- 12.2.3 Beckman Coulter Revenue in Biobanking Business (2021-2026)
- 12.2.4 Beckman Coulter Biobanking Product Portfolio
- 12.2.5 Beckman Coulter Recent Developments
- 12.3 Panasonic
- 12.3.1 Panasonic Company Information
- 12.3.2 Panasonic Business Overview
- 12.3.3 Panasonic Revenue in Biobanking Business (2021-2026)
- 12.3.4 Panasonic Biobanking Product Portfolio
- 12.3.5 Panasonic Recent Developments
- 12.4 SOL Group
- 12.4.1 SOL Group Company Information
- 12.4.2 SOL Group Business Overview
- 12.4.3 SOL Group Revenue in Biobanking Business (2021-2026)
- 12.4.4 SOL Group Biobanking Product Portfolio
- 12.4.5 SOL Group Recent Developments
- 12.5 Promega
- 12.5.1 Promega Company Information
- 12.5.2 Promega Business Overview
- 12.5.3 Promega Revenue in Biobanking Business (2021-2026)
- 12.5.4 Promega Biobanking Product Portfolio
- 12.5.5 Promega Recent Developments
- 12.6 Merck
- 12.6.1 Merck Company Information
- 12.6.2 Merck Business Overview
- 12.6.3 Merck Revenue in Biobanking Business (2021-2026)
- 12.6.4 Merck Biobanking Product Portfolio
- 12.6.5 Merck Recent Developments
- 12.7 Greiner Bio One
- 12.7.1 Greiner Bio One Company Information
- 12.7.2 Greiner Bio One Business Overview
- 12.7.3 Greiner Bio One Revenue in Biobanking Business (2021-2026)
- 12.7.4 Greiner Bio One Biobanking Product Portfolio
- 12.7.5 Greiner Bio One Recent Developments
- 12.8 Chart Industries
- 12.8.1 Chart Industries Company Information
- 12.8.2 Chart Industries Business Overview
- 12.8.3 Chart Industries Revenue in Biobanking Business (2021-2026)
- 12.8.4 Chart Industries Biobanking Product Portfolio
- 12.8.5 Chart Industries Recent Developments
- 12.9 Brooks Life Science
- 12.9.1 Brooks Life Science Company Information
- 12.9.2 Brooks Life Science Business Overview
- 12.9.3 Brooks Life Science Revenue in Biobanking Business (2021-2026)
- 12.9.4 Brooks Life Science Biobanking Product Portfolio
- 12.9.5 Brooks Life Science Recent Developments
- 12.10 Tecan Group
- 12.10.1 Tecan Group Company Information
- 12.10.2 Tecan Group Business Overview
- 12.10.3 Tecan Group Revenue in Biobanking Business (2021-2026)
- 12.10.4 Tecan Group Biobanking Product Portfolio
- 12.10.5 Tecan Group Recent Developments
- 12.11 QIAGEN
- 12.11.1 QIAGEN Company Information
- 12.11.2 QIAGEN Business Overview
- 12.11.3 QIAGEN Revenue in Biobanking Business (2021-2026)
- 12.11.4 QIAGEN Biobanking Product Portfolio
- 12.11.5 QIAGEN Recent Developments
- 12.12 BD
- 12.12.1 BD Company Information
- 12.12.2 BD Business Overview
- 12.12.3 BD Revenue in Biobanking Business (2021-2026)
- 12.12.4 BD Biobanking Product Portfolio
- 12.12.5 BD Recent Developments
- 12.13 Lifeline Scientific
- 12.13.1 Lifeline Scientific Company Information
- 12.13.2 Lifeline Scientific Business Overview
- 12.13.3 Lifeline Scientific Revenue in Biobanking Business (2021-2026)
- 12.13.4 Lifeline Scientific Biobanking Product Portfolio
- 12.13.5 Lifeline Scientific Recent Developments
- 12.14 Hamilton
- 12.14.1 Hamilton Company Information
- 12.14.2 Hamilton Business Overview
- 12.14.3 Hamilton Revenue in Biobanking Business (2021-2026)
- 12.14.4 Hamilton Biobanking Product Portfolio
- 12.14.5 Hamilton Recent Developments
- 12.15 So-Low
- 12.15.1 So-Low Company Information
- 12.15.2 So-Low Business Overview
- 12.15.3 So-Low Revenue in Biobanking Business (2021-2026)
- 12.15.4 So-Low Biobanking Product Portfolio
- 12.15.5 So-Low Recent Developments
- 12.16 TTP Labtech Ltd
- 12.16.1 TTP Labtech Ltd Company Information
- 12.16.2 TTP Labtech Ltd Business Overview
- 12.16.3 TTP Labtech Ltd Revenue in Biobanking Business (2021-2026)
- 12.16.4 TTP Labtech Ltd Biobanking Product Portfolio
- 12.16.5 TTP Labtech Ltd Recent Developments
- 12.17 Biolife Solutions
- 12.17.1 Biolife Solutions Company Information
- 12.17.2 Biolife Solutions Business Overview
- 12.17.3 Biolife Solutions Revenue in Biobanking Business (2021-2026)
- 12.17.4 Biolife Solutions Biobanking Product Portfolio
- 12.17.5 Biolife Solutions Recent Developments
- 12.18 DNA Genotek
- 12.18.1 DNA Genotek Company Information
- 12.18.2 DNA Genotek Business Overview
- 12.18.3 DNA Genotek Revenue in Biobanking Business (2021-2026)
- 12.18.4 DNA Genotek Biobanking Product Portfolio
- 12.18.5 DNA Genotek Recent Developments
- 12.19 Custom Biogenic Systems
- 12.19.1 Custom Biogenic Systems Company Information
- 12.19.2 Custom Biogenic Systems Business Overview
- 12.19.3 Custom Biogenic Systems Revenue in Biobanking Business (2021-2026)
- 12.19.4 Custom Biogenic Systems Biobanking Product Portfolio
- 12.19.5 Custom Biogenic Systems Recent Developments
- 12.20 LVL Technologies
- 12.20.1 LVL Technologies Company Information
- 12.20.2 LVL Technologies Business Overview
- 12.20.3 LVL Technologies Revenue in Biobanking Business (2021-2026)
- 12.20.4 LVL Technologies Biobanking Product Portfolio
- 12.20.5 LVL Technologies Recent Developments
- 12.21 BioRep
- 12.21.1 BioRep Company Information
- 12.21.2 BioRep Business Overview
- 12.21.3 BioRep Revenue in Biobanking Business (2021-2026)
- 12.21.4 BioRep Biobanking Product Portfolio
- 12.21.5 BioRep Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst